您要查找的是不是:
- Keywords Polysulfone membrane;Bioreactor;Severe hepatitis plasma;Bioartificial liver;Porcine hepatocytes; 聚砜膜;生物反应器;重肝患者血浆;生物人工肝;猪肝细胞;
- Keywords Chronic hepatitis B;Lamivudine-resistance;adefovir dipivoxil;umbilical cord blood mesenchymal stem cells;sever hepatitis plasma; 慢性乙型肝炎;拉米夫定耐药;阿德福韦酯;脐血间充质干细胞;重型肝炎血浆;
- Severe hepatitis plasma 重肝患者血浆
- Objective To evaluate the treatment of plasma exchange (PE) in patients with chronic severe hepatitis based on prothrombin activity (PTA). 摘要目的探讨根据凝血酶原活动度(PTA)预测重型肝炎高胆红素血症行血浆置换的临床疗效。
- Objective To observe the clinical effects of plasma exchange with artificial liver supporting system en patients with severe hepatitis. 摘要目的观察人工肝支持系统血浆置换治疗重型肝炎患者的临床疗效。
- Objective: To study the effect of prognosis of severe hepatitis. 目的:探讨影响重型肝炎预后的因素。
- Abstract: Objective: To study the effect of prognosis of severe hepatitis. 文摘:目的:探讨影响重型肝炎预后的因素。
- It is a kind of effective artificial liver treatment method of treating the severe hepatitis patient that BL-300 bilirubin adsorber unites HA-330 Choice Membrane plasma separator . 应用选择性血浆分离器(EC-4A)进行BL-300血浆胆红素吸附器串联血浆灌流器是治疗重型肝炎患者的一种有效的人工肝治疗方法。
- Objective To investigate the effects of plasma from patients with chronic severe hepatitis on C3A cell line in vitro, which can provide experimental data for C3A cell derived bioartificial liver. 目的 观察慢性重型肝炎及肝衰竭患者血浆对C3A细胞株的影响,为研究应用C3A细胞株的 生物反应器进行生物人工肝支持治疗提供实验依据。
- This patient developed severe hepatitis with hepatic decompensation. 该例患者患了重症肝炎,肝脏失代偿。
- The severe hepatitis is often seen in viral hepatitis caused by duplicate virus and twinborn women. 两种病毒以上的感染、双胎较易发生重症肝炎。
- Objective To survey the mutuality of chronic severe hepatitis on peripheral blood cell and its results. 目的通过对慢性重型肝炎患者的外周血象分析,观察慢性重型肝炎的外周血象与其预后的相关性。
- Objective To explore the value of ABO-incompatible liver transplantation in the treatment of severe hepatitis. 结论供受体ABO血型不合肝移植可以作为抢救重症肝炎病人的选择,尤其对O型血受体疗效较好。
- Objective To evaluate the curative effect of plasma-exchange therapy for severe hepatitis in artificial liver system. 目的评价人工肝支持系统中血浆置换治疗重型肝炎的疗效。
- Methods:Analyse the 115 severe hepatitis patients complications caused by using ALSS. 方法:统计分析人工肝支持系统治疗重症肝炎115次共23人次时并发症的发生情况。
- Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver. 目的 应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝 ,进一步评价其安全性和疗效。
- Results: sTC concentrations were closely correlated with the Ishak score(P<0.01,r=-0.56) in the patients with chronic hepatitis B and severe hepatitis. 结果 :sTC水平与慢性乙肝及重型肝炎患者肝组织病变程度Ishak计分呈明显负相关 (P <0 0 1;r =-0 5 6)。
- BLC, HBV-DNA load and STC is valuable in predicting the trend of CHB(moderate) and the diagnosis and prognosis of severe hepatitis in time. BLC、HBV-DNA载量和STC有助于预测慢性乙肝(中度)的发展趋势,对早期诊断重型肝炎和判断预后有重要价值。
- To decrease the mortality of the patients with severe hepatitis, we should adopt rational therapeutics and prevent complications in clinical practice. 临床治疗时应采用合理的治疗方法,预防并发症,以提高重型肝炎的生存率。
- Aim To observe the clinical therapeutic effects and adverse reaction of Lipo-PGE1 in treament of chronic severe hepatitis. 目的 观察前列腺素E1脂微球载体制剂 (凯时 ,Lipo PGE1)对慢性重症肝炎的治疗作用和副作用。